![Jodi Cook](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/07/2026
Jodi A. Cook is President & Chief Executive Officer at Skylark Bio, Inc. since 2022.
Dr. Cook is an Independent Director at Fennec Pharmaceuticals, Inc. since 2019.
Former roles include Audiology Director at Songbird Holdings LLC, Director-Hearing Aid Program at Mayo Clinic, Vice President-Clinical Research at InSound Medical, Inc., Head-Gene Therapy Strategy at PTC Therapeutics, Inc., and Chief Operating Officer at PTC Therapeutics GT, Inc. Education includes a doctorate from Arizona State University, an undergraduate degree from Loyola University Maryland, Inc., and a graduate degree from the University of South Carolina.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 10/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| FENNEC PHARMACEUTICALS INC. | Director/Miembro de la Junta | 24/09/2019 |
Skylark Bio, Inc.
 Skylark Bio, Inc. BiotechnologyHealth Technology Develops gene therapy solutions for neurology and hearing impairment | Director Ejecutivo | 01/12/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
| PTC THERAPEUTICS, INC. | Corporate Officer/Principal | 01/02/2020 |
Songbird Holdings LLC
 Songbird Holdings LLC Medical SpecialtiesHealth Technology Designs and manufactures hearing devices | Corporate Officer/Principal | - |
InSound Medical, Inc.
 InSound Medical, Inc. Medical SpecialtiesHealth Technology Develops and manufactures hearing devices | Corporate Officer/Principal | - |
Mayo Clinic
 Mayo Clinic Medical/Nursing ServicesHealth Services Operates medical clinics and hospitals | Corporate Officer/Principal | - |
PTC Therapeutics GT, Inc.
 PTC Therapeutics GT, Inc. Medical SpecialtiesHealth Technology Innovates DNA therapeutics, provides long-term efficacy for patients with debilitating & fata diseases | Director de Operaciones | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Fennec Pharmaceuticals, Inc.
 Fennec Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutic products which dedicated to improving the lives of children with cancer who experience hearing loss | Health Technology |
InSound Medical, Inc.
InSound Medical, Inc. Medical SpecialtiesHealth Technology Develops and manufactures hearing devices | Health Technology |
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Arizona State University
 Arizona State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loyola University Maryland, Inc.
 Loyola University Maryland, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of South Carolina
 University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Songbird Holdings LLC
Songbird Holdings LLC Medical SpecialtiesHealth Technology Designs and manufactures hearing devices | Health Technology |
Mayo Clinic
Mayo Clinic Medical/Nursing ServicesHealth Services Operates medical clinics and hospitals | Health Services |
PTC Therapeutics GT, Inc.
PTC Therapeutics GT, Inc. Medical SpecialtiesHealth Technology Innovates DNA therapeutics, provides long-term efficacy for patients with debilitating & fata diseases | Health Technology |
Skylark Bio, Inc.
Skylark Bio, Inc. BiotechnologyHealth Technology Develops gene therapy solutions for neurology and hearing impairment | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
